[1]
|
Yeh, C.C., Lai, C.Y., Chang, S.N., Hsieh, L.L., Tang, R., Sung, F.C. and Lin, Y.K. (2017) Polymorphisms of MTHFR C677T and A1298C Associated with Survival in Patients with Colorectal Cancer Treated with 5-Fluorouracil-Based Chemotherapy. International Journal of Clinical Oncology, 22, 484-493. https://doi.org/10.1007/s10147-016-1080-z
|
[2]
|
Cheok, M.H. and Evans, W.E. (2006) Acute Lymphoblastic Leu-kaemia: A Model for the Pharmacogenomics of Cancer Therapy. Nature Reviews Cancer, 6, 117-129. https://doi.org/10.1038/nrc1800
|
[3]
|
Weisberg, I.S., Jacques, P.F., Selhub, J., Bostom, A.G., Chen, Z., Curtis El-lison, R., Eckfeldt, J.H. and Rozen, R. (2001) The 1298A > C Polymorphism in Methylenetetrahydrofolate Reductase (MTHFR): In Vitro Expression and Association with Homocysteine. Atherosclerosis, 156, 409-415. https://doi.org/10.1016/S0021-9150(00)00671-7
|
[4]
|
Shen, S., Chen, X., Cai, J., Yu, J., Gao, J., et al. (2020) Ef-fect of Dasatinib vs Imatinib in the Treatment of Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leu-kemia: A Randomized Clinical Trial. JAMA Oncology, 6, 358-366. https://doi.org/10.1001/jamaoncol.2019.5868
|
[5]
|
Lopez-Lopez, E., Martin-Guerrero, I., Ballesteros, J. and Gar-cia-Orad, A. (2013) A Systematic Review and Meta-Analysis of MTHFR Polymorphisms in Methotrexate Toxicity Pre-diction in Pediatric Acute Lymphoblastic Leukemia. The Pharmacogenomics Journal, 13, 498-506. https://doi.org/10.1038/tpj.2012.44
|
[6]
|
Umerez, M., Gutierrez-Camino, Á., Muñoz-Maldonado, C., Mar-tin-Guerrero, I. and Garcia-Orad, A. (2017) MTHFR Polymorphisms in Childhood Acute Lymphoblastic Leukemia: In-fluence on Methotrexate Therapy. Pharmacogenomics and Personalized Medicine, 10, 69-78. https://doi.org/10.2147/PGPM.S107047
|
[7]
|
Li, Y., Pei, Y.X., Wang, L.N., Liang, C., Tang, Y.L., Zhang, X.L., Huang, L.B., Luo, X.Q. and Ke, Z.Y. (2020) MTHFR-C677T Gene Polymorphism and Susceptibility to Acute Lympho-blastic Leukemia in Children: A Meta-Analysis. Critical Reviews™ in Eukaryotic Gene Expression, 30, 125-136.
https://doi.org/10.1615/CritRevEukaryotGeneExpr.2020033468
|
[8]
|
陈先睿, 温红, 郭碧赟, 白海涛, 吴谨准, 黄建琪, 王玥. 闽南地区急性淋巴细胞白血病患儿亚甲基四氢叶酸还原酶基因多态性与甲氨蝶呤的相关性[J]. 中华实用儿科临床杂志, 2019, 34(14): 1068-1071.
|
[9]
|
Frikha, R., Jemaa, M.B., Frikha, F., Turki, I., Elloumi, M., Keskes, L., Kamoun, H. and Rebai, T. (2021) Involvement of C677T MTHFR Variant but Not A1298C in Methotrex-ate-Induced Toxicity in Acute Lymphoblastic Leukemia. Journal of Oncology Pharmacy Practice, 27, 1382-1387. https://doi.org/10.1177/1078155220951898
|
[10]
|
白小红, 牛佳慧, 倪美艳, 童荣生. MTHFR基因多态性与大剂量甲氨蝶呤治疗儿童急性淋巴细胞白血病的临床疗效及药物不良反应的相关性分析[J]. 中国临床药理学杂志, 2021, 37(22): 3056-3059.
|
[11]
|
Fukushima, H., Fukushima, T., Sakai, A., Suzuki, R., Nakajima-Yamaguchi, R., Koba-yashi, C., Iwabuchi, A., Saito, M., Yoshimi, A., Nakao, T., Kato, K., Tsuchida, M., Takahashi, H., Koike, K., Kiyokawa, N., Noguchi, E. and Sumazaki, R. (2013) Polymorphisms of MTHFR Associated with Higher Relapse/Death Ratio and Delayed Weekly MTX Administration in Pediatric Lymphoid Malignancies. Leukemia Research and Treatment, 2013, Article ID: 238528.
https://doi.org/10.1155/2013/238528
|
[12]
|
Hagleitner, M.M., Coenen, M.J., Aplenc, R., et al. (2014) The Role of the MTHFR 677C > T Polymorphism in Methotrexate-Induced Liver Toxicity: A Meta-Analysis in Patients with Cancer. The Pharmacogenomics Journal, 14, 115-119.
https://doi.org/10.1038/tpj.2013.19
|
[13]
|
Haase, R., Elsner, K., Merkel, N., Stiefel, M., Mauz-Körholz, C., Kramm, C.M. and Körholz, D. (2012) High dose Methotrexate Treatment in Childhood ALL: Pilot Study on the Impact of the MTHFR 677C > T and 1298A > C Polymorphisms on MTX-Related Toxicity. Klinische Pädiatrie, 224, 156-159. https://doi.org/10.1055/s-0032-1304623
|
[14]
|
Zgheib, N.K., Akra-Ismail, M., Aridi, C., Mahfouz, R., Abboud, M.R., Solh, H. and Muwakkit, S.A. (2012) Genetic Polymorphisms in Candidate Genes Predict Increased Toxicity with Methotrexate Therapy in Lebanese Children with Acute Lymphoblastic Leukemia. Pharmacogenet Genomics, 24, 387-396.
https://doi.org/10.1097/FPC.0000000000000069
|
[15]
|
朱忱, 王晓玲, 李晓玲. 急性淋巴细胞白血病患儿亚甲基四氢叶酸还原酶(MTHFR)C677T多态性与甲氨蝶呤毒性相关性的Meta分析[J]. 实用药物与临床, 2017, 20(9): 1009-1014.
|
[16]
|
Treviño, L.R., Shimasaki, N., Yang, W., Panetta, J.C., Cheng, C., Pei, D., Chan, D., Sparreboom, A., Giacomini, K.M., Pui, C.H., Evans, W.E. and Relling, M.V. (2009) Germline Genetic Variation in an Organic Anion Transporter Polypeptide Associated with Methotrexate Pharmacokinetics and Clinical Effects. Journal of Clinical Oncol-ogy, 27, 5972-5978.
https://doi.org/10.1200/JCO.2008.20.4156
|
[17]
|
Gutierrez-Camino, A., Lopez-Lopez, E. and Garcia-Orad, A. (2014) SLC19A1 Hot Spot for MTX Plasma Concentration. Medical Oncology, 31, Article No. 204. https://doi.org/10.1007/s12032-014-0204-4
|